Anti-TNBC agent-2 (3j), a purine derivative, acts as an anti-triple negative breast cancer (TNBC) therapeutic. It promotes apoptosis in MDA-MB-231 cells, while also inhibiting their migration and angiogenesis. Moreover, anti-TNBC agent-2 suppresses tumor
Molecular Weight:
542.09
CAS Number:
[2422001-22-5]
Formula:
C28H37ClFN7O
Target:
Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted